Screener

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest

Name: BridgeBio Pharma Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

BridgeBio Pharma·Business Segments·1 segment·Rolls up to Pre-Tax Income

Breakdown

Segment	Q3 '25	Q4 '25	Q2 '26
Business Segments	-$186.48M	-$194.76M	-$155.89M
Total	-$186.48M	-$194.76M	-$155.89M

Segments

Business SegmentsView metric